related documents
- Efficacy and Safety of Rivaroxaban in Patients With PAD Undergoing Lower Extremity Revascularization for Critical Limb Ischemia: Insights From VOYAGER PAD Conferences
- Rivaroxaban Plus Aspirin versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From Voyager PAD Conferences